Sick woman with Long COVID lying in bed

Gene Expression Changes Could Be Behind Long-Haul COVID-19 Symptoms

Exposure to the SARS-CoV-2 spike protein alone was enough to change baseline gene expression in airway cells in early stage research, suggesting a possible cause for long COVID symptoms.
binary code pattern

The Biomarker Future is Digital

As demand continues to grow for more data to inform precision medicine, digital biomarkers represent a new class of biomarkers that provide information in real time.

Genomind Launching Enhanced Mental Health Biomarker Test

Genomind said today it will launch an enhanced version of its mental health genetic test that will feature a new, more focused report and...
The combination of Bristol-Myers Squibb (BMS)'s marketed cancer immunotherapies Opdivo (nivolumab) plus a low dose of Yervoy (ipilimumab) showed durable clinical benefit in a Phase II trial as a first-line treatment in patients with microsatellite instability-high (MSI-H) or DNA mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)

Guardant Throws Hat in Early Cancer Detection Ring with CRC Test

Guardant Reveal, is a plasma-only ctDNA test for detection of early-stage colorectal cancer, with additional cancer types to follow. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019.
Light micrograph of metastases in breast tissue

Triple Negative Breast Cancer Recurrence Prediction Method Developed

Women whose plasma contained circulating tumor DNA had only a 56% chance of being cancer-free two years following chemotherapy and surgery, while those without it had an 81% chance the cancer would not return in the same time span.

PerkinElmer Genomics, U. of Iowa Develop FSHD Assay Based on Bionano’s Saphyr

Bionano Genomics announced at the American Society of Human Genetics (ASHG) annual meeting in Houston that PerkinElmer Genomics and the University of Iowa have...
Protoplasmic and fibrous astrocytes, illustration

Genetic Change Triggers Brain Cells to Cause ALS

A genetic change that occurs in astrocyte cells in the brain causes them to become ‘reactive’ and trigger the onset of ALS. Researchers hope this finding will help them to develop better treatments for this fatal condition.
Cloned Faces with digital background

Whole-Genome Sequencing Comes of Age in Clinical Care

In this Clinical OMICs KEYNOTE webinar, sponsored by Illumina, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field.
Mesh or net with lines and geometrics shapes detail.3d illustration

Clinical Applications of Spatial Gene Expression

Join us for this live Clinical OMICs webinar, sponsored by 10X Genomics, our distinguished presenters, Dr. Anna Lyubetskaya and Dr. Eugene Drokhlyansky, will explore the potential of spatial gene expression for various applications in clinical cohorts.

Betting on Blood: Liquid Biopsy Companies Pursuing both Early- and Late-Stage Cancer Detection

It’s an aspirational goal: develop a simple blood test that can detect cancer cells in an asymptomatic patient, locate the tissue of origin, and...

Featured